Cognitive impairment in amyotrophic lateral sclerosis

Summary Amyotrophic lateral sclerosis (ALS) is a motor neuron disease that has sporadic and inherited forms. ALS is the most common neurodegenerative disorder of young and middle-aged adults, and few treatments are available. Although the degeneration predominantly affects the motor system, cognitiv...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lancet neurology 2007-11, Vol.6 (11), p.994-1003
Hauptverfasser: Phukan, Julie, MB, Pender, Niall P, PhD, Hardiman, Orla, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1003
container_issue 11
container_start_page 994
container_title Lancet neurology
container_volume 6
creator Phukan, Julie, MB
Pender, Niall P, PhD
Hardiman, Orla, MD
description Summary Amyotrophic lateral sclerosis (ALS) is a motor neuron disease that has sporadic and inherited forms. ALS is the most common neurodegenerative disorder of young and middle-aged adults, and few treatments are available. Although the degeneration predominantly affects the motor system, cognitive and behavioural symptoms have been described for over a century, and there is evidence that ALS and frontotemporal dementia overlap clinically, radiologically, pathologically, and genetically. Cognitive decline in ALS is characterised by personality change, irritability, obsessions, poor insight, and pervasive deficits in frontal executive tests. This presentation is consistent with the changes to character, social conduct, and executive function in frontotemporal dementia. We highlight genetic, imaging, and neuropathological evidence that non-motor systems are affected in ALS and explain the importance of recent discoveries. We review studies of cognitive impairment in ALS and common neuropsychological test results. We also provide advice about clinical assessment of frontotemporal dysfunction in patients with ALS, and suggest future research. Understanding of cognitive impairment in ALS will improve care for patients and their families and provide valuable insights into the pathogenesis of neurodegeneration.
doi_str_mv 10.1016/S1474-4422(07)70265-X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68409972</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S147444220770265X</els_id><sourcerecordid>1668635961</sourcerecordid><originalsourceid>FETCH-LOGICAL-c497t-b608144caeb7525f7b02a7c766e29999baa90c82bd599ba6b086e625aaa7587a3</originalsourceid><addsrcrecordid>eNqFkMtKAzEUhoMotlYfQRlciC5GkzSXmY0ixRsUXKjQXcikp5o6l5rMFPr2ZjqlQjdmkwvf-XLOj9ApwdcEE3HzRphkMWOUXmJ5JTEVPJ7sof7mWfD97ZnSHjryfo4xJSwhh6hHZMo44cM-4qPqs7S1XUJki4W2roCyjmwZ6WJV1a5afFkT5boGp_PImxxc5a0_RgcznXs42ewD9PH48D56jsevTy-j-3FsWCrrOBM4IYwZDZnklM9khqmWRgoBNA0r0zrFJqHZlLcXkeFEgKBcay15IvVwgC4678JVPw34WhXWG8hzXULVeCUShtNU0gCe74DzqnFl6E1RHFqQjA8DxDvIhCG8g5laOFtot1IEqzZUtQ5VtYkpLNU6VDUJdWcbeZMVMP2r2qQYgLsOgJDF0oJT3lgoDUytA1OraWX__eJ2x2ByW1qj829Ygd8OQ5QPdZ2kdWC5NkyGv5aXmuA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201447453</pqid></control><display><type>article</type><title>Cognitive impairment in amyotrophic lateral sclerosis</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Phukan, Julie, MB ; Pender, Niall P, PhD ; Hardiman, Orla, MD</creator><creatorcontrib>Phukan, Julie, MB ; Pender, Niall P, PhD ; Hardiman, Orla, MD</creatorcontrib><description>Summary Amyotrophic lateral sclerosis (ALS) is a motor neuron disease that has sporadic and inherited forms. ALS is the most common neurodegenerative disorder of young and middle-aged adults, and few treatments are available. Although the degeneration predominantly affects the motor system, cognitive and behavioural symptoms have been described for over a century, and there is evidence that ALS and frontotemporal dementia overlap clinically, radiologically, pathologically, and genetically. Cognitive decline in ALS is characterised by personality change, irritability, obsessions, poor insight, and pervasive deficits in frontal executive tests. This presentation is consistent with the changes to character, social conduct, and executive function in frontotemporal dementia. We highlight genetic, imaging, and neuropathological evidence that non-motor systems are affected in ALS and explain the importance of recent discoveries. We review studies of cognitive impairment in ALS and common neuropsychological test results. We also provide advice about clinical assessment of frontotemporal dysfunction in patients with ALS, and suggest future research. Understanding of cognitive impairment in ALS will improve care for patients and their families and provide valuable insights into the pathogenesis of neurodegeneration.</description><identifier>ISSN: 1474-4422</identifier><identifier>EISSN: 1474-4465</identifier><identifier>DOI: 10.1016/S1474-4422(07)70265-X</identifier><identifier>PMID: 17945153</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Alzheimer's disease ; Amyotrophic lateral sclerosis ; Amyotrophic Lateral Sclerosis - psychology ; Brain damage ; Cognition Disorders - diagnosis ; Cognition Disorders - epidemiology ; Cognition Disorders - etiology ; Cognition Disorders - psychology ; Cognitive ability ; Dementia ; Dementia - etiology ; Genes ; Growth factors ; Humans ; Incidence ; Motor neurone disease ; Mutation ; Neurodegeneration ; Neurology ; Neuropathology ; Neuropsychological Tests ; Pathology ; Prevalence</subject><ispartof>Lancet neurology, 2007-11, Vol.6 (11), p.994-1003</ispartof><rights>Elsevier Ltd</rights><rights>2007 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Nov 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c497t-b608144caeb7525f7b02a7c766e29999baa90c82bd599ba6b086e625aaa7587a3</citedby><cites>FETCH-LOGICAL-c497t-b608144caeb7525f7b02a7c766e29999baa90c82bd599ba6b086e625aaa7587a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/201447453?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993,64383,64385,64387,72239</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17945153$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Phukan, Julie, MB</creatorcontrib><creatorcontrib>Pender, Niall P, PhD</creatorcontrib><creatorcontrib>Hardiman, Orla, MD</creatorcontrib><title>Cognitive impairment in amyotrophic lateral sclerosis</title><title>Lancet neurology</title><addtitle>Lancet Neurol</addtitle><description>Summary Amyotrophic lateral sclerosis (ALS) is a motor neuron disease that has sporadic and inherited forms. ALS is the most common neurodegenerative disorder of young and middle-aged adults, and few treatments are available. Although the degeneration predominantly affects the motor system, cognitive and behavioural symptoms have been described for over a century, and there is evidence that ALS and frontotemporal dementia overlap clinically, radiologically, pathologically, and genetically. Cognitive decline in ALS is characterised by personality change, irritability, obsessions, poor insight, and pervasive deficits in frontal executive tests. This presentation is consistent with the changes to character, social conduct, and executive function in frontotemporal dementia. We highlight genetic, imaging, and neuropathological evidence that non-motor systems are affected in ALS and explain the importance of recent discoveries. We review studies of cognitive impairment in ALS and common neuropsychological test results. We also provide advice about clinical assessment of frontotemporal dysfunction in patients with ALS, and suggest future research. Understanding of cognitive impairment in ALS will improve care for patients and their families and provide valuable insights into the pathogenesis of neurodegeneration.</description><subject>Alzheimer's disease</subject><subject>Amyotrophic lateral sclerosis</subject><subject>Amyotrophic Lateral Sclerosis - psychology</subject><subject>Brain damage</subject><subject>Cognition Disorders - diagnosis</subject><subject>Cognition Disorders - epidemiology</subject><subject>Cognition Disorders - etiology</subject><subject>Cognition Disorders - psychology</subject><subject>Cognitive ability</subject><subject>Dementia</subject><subject>Dementia - etiology</subject><subject>Genes</subject><subject>Growth factors</subject><subject>Humans</subject><subject>Incidence</subject><subject>Motor neurone disease</subject><subject>Mutation</subject><subject>Neurodegeneration</subject><subject>Neurology</subject><subject>Neuropathology</subject><subject>Neuropsychological Tests</subject><subject>Pathology</subject><subject>Prevalence</subject><issn>1474-4422</issn><issn>1474-4465</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkMtKAzEUhoMotlYfQRlciC5GkzSXmY0ixRsUXKjQXcikp5o6l5rMFPr2ZjqlQjdmkwvf-XLOj9ApwdcEE3HzRphkMWOUXmJ5JTEVPJ7sof7mWfD97ZnSHjryfo4xJSwhh6hHZMo44cM-4qPqs7S1XUJki4W2roCyjmwZ6WJV1a5afFkT5boGp_PImxxc5a0_RgcznXs42ewD9PH48D56jsevTy-j-3FsWCrrOBM4IYwZDZnklM9khqmWRgoBNA0r0zrFJqHZlLcXkeFEgKBcay15IvVwgC4678JVPw34WhXWG8hzXULVeCUShtNU0gCe74DzqnFl6E1RHFqQjA8DxDvIhCG8g5laOFtot1IEqzZUtQ5VtYkpLNU6VDUJdWcbeZMVMP2r2qQYgLsOgJDF0oJT3lgoDUytA1OraWX__eJ2x2ByW1qj829Ygd8OQ5QPdZ2kdWC5NkyGv5aXmuA</recordid><startdate>20071101</startdate><enddate>20071101</enddate><creator>Phukan, Julie, MB</creator><creator>Pender, Niall P, PhD</creator><creator>Hardiman, Orla, MD</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20071101</creationdate><title>Cognitive impairment in amyotrophic lateral sclerosis</title><author>Phukan, Julie, MB ; Pender, Niall P, PhD ; Hardiman, Orla, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c497t-b608144caeb7525f7b02a7c766e29999baa90c82bd599ba6b086e625aaa7587a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Alzheimer's disease</topic><topic>Amyotrophic lateral sclerosis</topic><topic>Amyotrophic Lateral Sclerosis - psychology</topic><topic>Brain damage</topic><topic>Cognition Disorders - diagnosis</topic><topic>Cognition Disorders - epidemiology</topic><topic>Cognition Disorders - etiology</topic><topic>Cognition Disorders - psychology</topic><topic>Cognitive ability</topic><topic>Dementia</topic><topic>Dementia - etiology</topic><topic>Genes</topic><topic>Growth factors</topic><topic>Humans</topic><topic>Incidence</topic><topic>Motor neurone disease</topic><topic>Mutation</topic><topic>Neurodegeneration</topic><topic>Neurology</topic><topic>Neuropathology</topic><topic>Neuropsychological Tests</topic><topic>Pathology</topic><topic>Prevalence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Phukan, Julie, MB</creatorcontrib><creatorcontrib>Pender, Niall P, PhD</creatorcontrib><creatorcontrib>Hardiman, Orla, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Lancet neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Phukan, Julie, MB</au><au>Pender, Niall P, PhD</au><au>Hardiman, Orla, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cognitive impairment in amyotrophic lateral sclerosis</atitle><jtitle>Lancet neurology</jtitle><addtitle>Lancet Neurol</addtitle><date>2007-11-01</date><risdate>2007</risdate><volume>6</volume><issue>11</issue><spage>994</spage><epage>1003</epage><pages>994-1003</pages><issn>1474-4422</issn><eissn>1474-4465</eissn><coden>LANCAO</coden><abstract>Summary Amyotrophic lateral sclerosis (ALS) is a motor neuron disease that has sporadic and inherited forms. ALS is the most common neurodegenerative disorder of young and middle-aged adults, and few treatments are available. Although the degeneration predominantly affects the motor system, cognitive and behavioural symptoms have been described for over a century, and there is evidence that ALS and frontotemporal dementia overlap clinically, radiologically, pathologically, and genetically. Cognitive decline in ALS is characterised by personality change, irritability, obsessions, poor insight, and pervasive deficits in frontal executive tests. This presentation is consistent with the changes to character, social conduct, and executive function in frontotemporal dementia. We highlight genetic, imaging, and neuropathological evidence that non-motor systems are affected in ALS and explain the importance of recent discoveries. We review studies of cognitive impairment in ALS and common neuropsychological test results. We also provide advice about clinical assessment of frontotemporal dysfunction in patients with ALS, and suggest future research. Understanding of cognitive impairment in ALS will improve care for patients and their families and provide valuable insights into the pathogenesis of neurodegeneration.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>17945153</pmid><doi>10.1016/S1474-4422(07)70265-X</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1474-4422
ispartof Lancet neurology, 2007-11, Vol.6 (11), p.994-1003
issn 1474-4422
1474-4465
language eng
recordid cdi_proquest_miscellaneous_68409972
source MEDLINE; ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland
subjects Alzheimer's disease
Amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis - psychology
Brain damage
Cognition Disorders - diagnosis
Cognition Disorders - epidemiology
Cognition Disorders - etiology
Cognition Disorders - psychology
Cognitive ability
Dementia
Dementia - etiology
Genes
Growth factors
Humans
Incidence
Motor neurone disease
Mutation
Neurodegeneration
Neurology
Neuropathology
Neuropsychological Tests
Pathology
Prevalence
title Cognitive impairment in amyotrophic lateral sclerosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T06%3A46%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cognitive%20impairment%20in%20amyotrophic%20lateral%20sclerosis&rft.jtitle=Lancet%20neurology&rft.au=Phukan,%20Julie,%20MB&rft.date=2007-11-01&rft.volume=6&rft.issue=11&rft.spage=994&rft.epage=1003&rft.pages=994-1003&rft.issn=1474-4422&rft.eissn=1474-4465&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1474-4422(07)70265-X&rft_dat=%3Cproquest_cross%3E1668635961%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=201447453&rft_id=info:pmid/17945153&rft_els_id=1_s2_0_S147444220770265X&rfr_iscdi=true